The Impact of Copay Accumulators and Maximizers on Treatment Patterns, Adherence, and Costs Among Patients with Major Depressive and Bipolar Disorders Treated with Branded Therapies [0.03%]
自付额累加器和最大化器对接受品牌药物治疗的主要抑郁障碍和双相情感障碍患者的影响
Onur Baser,Katarzyna Rodchenko,Heidi C Waters et al.
Onur Baser et al.
Copay accumulator (CA) and copay maximizer (CM) programs in the United States, which prevent manufacturer copay assistance from counting toward deductibles or out-of-pocket (OOP) maximums, are increasingly used, raising concerns about costs...
Criterion-Related Validity and Reliability of a Measurement Tool for Medical Doctors' Work-Related Quality of Life in Japan [0.03%]
日本医生职业生活质量测评工具的准则效度和信度研究
Miyuki Ezura,Katsuhiko Sawada,Yusuke Takushima et al.
Miyuki Ezura et al.
Objective: This confirmatory survey aimed to verify the criterion-related validity and reliability of the final version of the Medical Doctors' Work-Related Quality of Life Questionnaire (WQMD-9), following partial revision of its content. ...
Network Meta-Analysis of Bevacizumab Gamma Versus Competing Interventions for Treating Neovascular Age-Related Macular Degeneration in the United Kingdom [0.03%]
英国贝伐单抗γ与竞争疗法治疗年龄相关性黄斑变性的网络meta分析研究
Maria Lorenzi,Stephen Ebohon,Jennifer Kissner et al.
Maria Lorenzi et al.
This study aimed to determine the relative efficacy of bevacizumab gamma (an ophthalmic formulation of bevacizumab) versus alternative interventions relevant to the treatment of neovascular age-related macular degeneration (nAMD) in the Uni...
How the Stakeholders' Perception Contributes to the Pharmaceutical Strategies: A Regional Case Study in Latin America [0.03%]
利益攸关方的认知如何影响制药业战略？拉丁美洲地区案例研究
Talita da Silva Ferreira,Giovanni M Pauletti,Luis Vázquez-Suárez
Talita da Silva Ferreira
Background: Stakeholders' perception plays a crucial role in shaping pharmaceutical strategies. Stakeholders are groups interested in pharmaceutical companies' success and outcomes. Stakeholders' perceptions are multifaceted and impact phar...
Balancing Costs and Clinical Outcomes: A Cost-Effectiveness Study of PICC Types Across Chinese Healthcare Settings [0.03%]
成本与临床效果的权衡：中国医疗机构输液港与PICC成本效益研究
Jia Xu,Hossein Zare,Xia Yan et al.
Jia Xu et al.
Long-term intravenous therapies often necessitate the use of peripherally inserted central catheters (PICCs). Antimicrobial-coated PICCs have been introduced to minimize central line-associated bloodstream infections (CLABSIs). A decision-a...
Clinical and Economic Evidence Supporting the Value of Fluorescence Imaging of Bacteria in Wound Care [0.03%]
用于伤口护理的细菌荧光成像的临床和经济价值证据支持
Jonathan Johnson,Gregory Bohn
Jonathan Johnson
Wound infection significantly hinders the healing process. Clinical signs and symptoms (CSS) of infection are used to assess the presence of infection and guide whether to intervene. However, CSS may not be dependable, lacking sensitivity a...
Examining State Policies and Administrative Factors as Determinants of Consumer-Reported Unmet Service Needs in Publicly Funded Home- and Community-Based Services in the United States [0.03%]
美国公共资助的家庭和社区为基础的服务中消费者报告的未得到满足的服务需求的状态政策和行政决定因素的考察研究
Romil R Parikh,Tetyana P Shippee,Benjamin Langworthy et al.
Romil R Parikh et al.
Access to home- and community-based services (HCBSs) varies substantially between states. Yet, it is unknown how state-level policies and administrative factors impact consumer-reported unmet service needs, an important indicator of HCBS ac...
A Data-Driven Approach for Estimating Type 2 Diabetes-Related Costs in Greece [0.03%]
基于数据的糖尿病相关成本估计方法及希腊地区的应用研究
Elisavet Nika,Thomas Tsiampalis,Athanasios Sachlas et al.
Elisavet Nika et al.
Type 2 diabetes (T2D) constitutes a major health problem, reaching alarming rates over the last decades, especially due to contemporary lifestyle and associated obesogenic environments, as well as the aging population. Diabetes not only cau...
Vaccine Development, Its Implementation and Price Setting: A Historical Perspective with Proposed Ways to Move Forward [0.03%]
疫苗研发、实施及其定价：基于历史经验的未来发展方向
Baudouin Standaert,Oleksandr Topachevskyi,Olivier Ethgen
Baudouin Standaert
Vaccination has resulted in substantial public health benefits for human populations worldwide since it was first introduced more than a century ago. This article presents an overview of the history of vaccine development, its implementatio...
EU Joint Clinical Assessment: A Framework for Optimising Use with Cost-Effectiveness Decision-Making [0.03%]
欧盟联合临床评估：与成本效益决策优化使用的框架
Adam Johns,André Andrade,Sukhvinder Johal et al.
Adam Johns et al.
The introduction of the European Union (EU) Joint Clinical Assessment (JCA) under Regulation (EU) 2021/2282 marks a transformative step in harmonizing health technology assessments (HTAs) across EU member states. This article explores the i...